Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.41 USD | 0.00% | -1.17% | +16.44% |
17/05 | UBS Adjusts Price Target on Hercules Capital to $18.50 From $18, Maintains Neutral Rating | MT |
15/05 | Adaptimmune Therapeutics Enters Into $125 Million Term Loan Facility With Hercules Capital | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.44% | 3.1B | |
+12.82% | 1.77B | |
-11.54% | 1.21B | |
+17.80% | 790M | |
+9.81% | 673M | |
+28.17% | 570M | |
-4.17% | 508M | |
+34.47% | 502M | |
+80.62% | 342M | |
+3.90% | 312M |
- Stock Market
- Equities
- HTGC Stock
- News Hercules Capital, Inc.
- Oppenheimer Adjusts Hercules Capital Price Target to $15 From $13, Maintains Perform Rating